$ Value
$0
Shares
5,000
Price
$0
Filed
Nov 3
Insider
Name
Hopkinson Craig C.
Title
EVP R&D, Chief Medical Officer
CIK
0001730048
Roles
Transaction Details
Transaction Date
2025-11-03
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
40,104
Footnotes
This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025. | This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.34 to $30.56. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. | These options are fully vested in accordance with their terms.
Filing Info
Hopkinson Craig C.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | ALKS | M | $97K |
| 2026-04-01 | ALKS | ▼ | $320K |
| 2026-04-01 | ALKS | M | $0 |
| 2025-12-03 | ALKS | M | $72K |
| 2025-12-03 | ALKS | ▼ | $112K |
| 2025-12-03 | ALKS | M | $0 |
| 2025-12-01 | ALKS | ▼ | $117K |
| 2025-11-03 | ALKS | M | $97K |
| 2025-11-03 | ALKS | ▼ | $273K |
| 2025-11-03 | ALKS | M | $0 |
Other Insiders at ALKS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Lurker Nancy | — | — | 2026-04-11 |
|
Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
|
— | $70K | 2026-04-06 |
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
|
— | $320K | 2026-04-01 |